In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand.

This market research report provides an in-depth analysis of the Injectable Drug Delivery Market, projecting significant growth from 2025 to 2035. The global market is expected to expand from USD 704.

Optimizing sustainability is another design aspect where customization is looking to push boundaries. Specifically, there’s ...

In a world where health and safety are paramount, the disposable syringes market stands as a pillar of progress, offering not just convenience but also enhanced safety measures. With a valuation of ...